3 ‘Strong Buy’ Stocks Under $10 to Watch in October for 100%+ Upside
Low-priced stocks can carry high risk but also offer solid upside potential. On Wall Street, analysts currently rate three such stocks a Strong Buy...
Immuneering Corp (IMRX)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Levin Capital Strategies John A. Levin | 212,000 | $868,140 | -49% | 0.06% |
| 2. | Fisher Asset Management Ken Fisher | 115,954 | $474,831 | +32% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.56 | 2,400 | $10,948.08 | 2,315,252 | 2026-06-23 | Filing | |
| $4.15 | 6,035 | $25,045.25 | 382,531 | 2026-06-15 | Filing | |
| $4.76 | 5,250 | $24,990.00 | 11,050 | 2026-01-16 | Filing | |
| $4.67 | 21,645 | $101,041.02 | 74,530 | 2026-01-15 | Filing | |
| $4.57 | 2,298 | $10,501.86 | 376,496 | 2026-01-15 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.90 | 398,600 | $1,155,940.00 | 2,895,273 | 2024-04-01 | Filing | |
| $2.97 | 280 | $831.60 | 3,293,873 | 2024-04-01 | Filing | |
| $2.98 | 10 | $29.80 | 3,294,153 | 2024-04-01 | Filing | |
| $3.01 | 10 | $30.10 | 3,294,163 | 2024-04-01 | Filing | |
| $3.03 | 600 | $1,818.00 | 3,294,173 | 2024-04-01 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 2,708,559 | $11,091,549 | 1.76% | |
| 2. | 1,374,279 | $5,629,137 | 0% | |
| 3. | 862,500 | $3,531,938 | 0.8% | |
| 4. | 784,951 | $3,214,374 | 0% | |
| 5. | 185,913 | $761,316 | 0.52% |
News See All
Immuneering Corporation (NASDAQ:IMRX) Q3 2025 Earnings Call Transcript
Immuneering Corporation (NASDAQ:IMRX) Q3 2025 Earnings Call Transcript November 12, 2025Immuneering Corporation misses on earnings expectations. Reported EPS is $-0.38 EPS, expectations were $-0.37.
Positive Trial Data Supports 43% Upside for Immuneering Corporation (IMRX)
Immuneering Corporation (NASDAQ:IMRX) is among the best fast money stocks to buy now.
11 Best Fast Money Stocks to Buy Now
In this article, we will take a look at some of the best fast money stocks to buy now. In this fast-paced world, most people have become impatient.
Immuneering Corporation (NASDAQ:IMRX) Q4 2022 Earnings Call Transcript
Immuneering Corporation (NASDAQ:IMRX) Q4 2022 Earnings Call Transcript March 6, 2023 Operator: Welcome to the Immuneering Fourth Quarter and Full Year 2022 Financial Results and Corporate Update Conference...
Hedge Fund Resource Center